• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸合酶抑制物可抑制膀胱癌细胞中的 P-AKT 并诱导其凋亡。

Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer.

机构信息

Department of Urology, The Affiliated First People's Hospital of Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

出版信息

Urology. 2012 Aug;80(2):484.e9-15. doi: 10.1016/j.urology.2012.02.046. Epub 2012 May 2.

DOI:10.1016/j.urology.2012.02.046
PMID:22554590
Abstract

OBJECTIVE

To investigate the role of fatty acid synthase (FASN) in bladder transitional cell carcinoma (BTCC).

METHODS

FASN expression was investigated in non-muscle-invasive BTCC tissue specimens by immunohistochemistry and BTCC cell lines by Western blot. After treatment with FASN-siRNA or FASN inhibitor cerulenin (Cer), the proliferation and apoptosis of BTCC cell lines 5637 and 253 J were determined by cell counting Kit-8 (CCK8) assay and flow cytometry respectively. The expression of p-AKT, cyclin D1 (CCND1), and apoptosis-related proteins were detected by Western blot.

RESULTS

High levels of FASN expression were observed in 59% (32/54) of non-muscle-invasive BTCC tissue specimens, and FASN expression was associated with histologic grade (P < .05) and recurrence (P < .05). FASN expression was high in 6 BTCC cell lines. FASN inhibitor Cer and FASN-siRNA produced the increased apoptosis and decreased proliferation of bladder cancer cells, and caused inactivity of AKT and downregulation of CCND1. Furthermore, treatment of BTCC cell lines with Cer resulted in apoptosis via the caspase-dependent pathway involving inactivation of antiapoptotic bcl-2 protein.

CONCLUSION

Our data suggest that FASN plays an important role in BTCC development. Targeting FASN may be a new therapeutic strategy for BTCC.

摘要

目的

研究脂肪酸合酶(FASN)在膀胱移行细胞癌(BTCC)中的作用。

方法

通过免疫组织化学和 BTCC 细胞系的 Western blot 检测非肌肉浸润性 BTCC 组织标本中 FASN 的表达。用 FASN-siRNA 或 FASN 抑制剂 cerulenin(Cer)处理 BTCC 细胞系 5637 和 253 J 后,分别通过细胞计数试剂盒-8(CCK8)检测和流式细胞术检测 BTCC 细胞系的增殖和凋亡。通过 Western blot 检测 p-AKT、细胞周期蛋白 D1(CCND1)和凋亡相关蛋白的表达。

结果

在 59%(32/54)的非肌肉浸润性 BTCC 组织标本中观察到 FASN 表达水平升高,FASN 表达与组织学分级(P <.05)和复发(P <.05)有关。在 6 种 BTCC 细胞系中 FASN 表达较高。FASN 抑制剂 Cer 和 FASN-siRNA 增加了膀胱癌细胞的凋亡,降低了其增殖,并导致 AKT 失活和 CCND1 下调。此外,Cer 处理 BTCC 细胞系通过 caspase 依赖性途径导致凋亡,涉及抗凋亡 bcl-2 蛋白的失活。

结论

我们的数据表明,FASN 在 BTCC 发展中起重要作用。靶向 FASN 可能是 BTCC 的一种新的治疗策略。

相似文献

1
Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer.脂肪酸合酶抑制物可抑制膀胱癌细胞中的 P-AKT 并诱导其凋亡。
Urology. 2012 Aug;80(2):484.e9-15. doi: 10.1016/j.urology.2012.02.046. Epub 2012 May 2.
2
Downregulation of fatty acid synthase complex suppresses cell migration by targeting phosphor-AKT in bladder cancer.脂肪酸合酶复合物的下调通过靶向磷酸化AKT抑制膀胱癌中的细胞迁移。
Mol Med Rep. 2016 Feb;13(2):1845-50. doi: 10.3892/mmr.2015.4746. Epub 2015 Dec 30.
3
[Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].[胱天蛋白酶-3和Bcl-2在膀胱移行细胞癌中的表达及其意义]
Ai Zheng. 2004 Feb;23(2):181-4.
4
Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.甲状腺乳头状癌亚组中的脂肪酸合酶与AKT信号通路
J Clin Endocrinol Metab. 2008 Oct;93(10):4088-97. doi: 10.1210/jc.2008-0503. Epub 2008 Aug 5.
5
High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.中东患者结直肠癌中脂肪酸合酶表达的高患病率及其作为治疗靶点的潜在作用。
Am J Gastroenterol. 2009 Jul;104(7):1790-801. doi: 10.1038/ajg.2009.230. Epub 2009 Jun 2.
6
Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.抗癌细胞和非肿瘤细胞中抗脂肪生成剂的治疗和毒理学评价。
Basic Clin Pharmacol Toxicol. 2012 Jun;110(6):494-503. doi: 10.1111/j.1742-7843.2011.00844.x. Epub 2012 Jan 16.
7
[The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].[PAK1蛋白表达在膀胱移行细胞癌中的临床病理意义]
Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2710-3.
8
[Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].[环氧化酶-2在人移行细胞膀胱癌中的表达]
Ai Zheng. 2002 Nov;21(11):1212-6.
9
Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway.脂肪酸合酶通过 HER2-PI3K/Akt 信号通路调节结直肠癌细胞的增殖和迁移。
Nutr Cancer. 2012 Aug;64(6):864-70. doi: 10.1080/01635581.2012.701704. Epub 2012 Aug 3.
10
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.与肿瘤相关脂肪酸合酶依赖性乳腺癌细胞增殖和存活相关的新型信号分子:外源性膳食脂肪酸、p53-p21WAF1/CIP1、ERK1/2 MAPK、p27KIP1、BRCA1和NF-κB的作用
Int J Oncol. 2004 Mar;24(3):591-608.

引用本文的文献

1
Exploration and validation of a novel reactive oxygen species-related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer.探索并验证一种用于预测膀胱癌患者预后及化疗反应的新型活性氧相关特征。
Front Immunol. 2024 Dec 19;15:1493528. doi: 10.3389/fimmu.2024.1493528. eCollection 2024.
2
Two metabolic enzymes, LDH and FASN, serum levels in Bladder cancer patients.两种代谢酶,即乳酸脱氢酶(LDH)和脂肪酸合酶(FASN)在膀胱癌患者中的血清水平。
Caspian J Intern Med. 2024 Aug 30;15(4):636-643. doi: 10.22088/cjim.15.4.636. eCollection 2024 Fall.
3
The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment.
miRNAs 在预测膀胱癌复发和治疗耐药中的作用。
Int J Mol Sci. 2023 Jan 4;24(2):964. doi: 10.3390/ijms24020964.
4
Targeting Energy Metabolism in Cancer Treatment.靶向癌症治疗中的能量代谢。
Int J Mol Sci. 2022 May 16;23(10):5572. doi: 10.3390/ijms23105572.
5
Epigallocatechin gallate triggers apoptosis by suppressing de novo lipogenesis in colorectal carcinoma cells.没食子酸表没食子儿茶素酯通过抑制结直肠癌细胞从头合成脂质来诱导细胞凋亡。
FEBS Open Bio. 2022 May;12(5):937-958. doi: 10.1002/2211-5463.13391. Epub 2022 Mar 17.
6
Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.鉴定与膀胱癌生存相关的新型代谢相关基因特征。
BMC Cancer. 2021 Nov 24;21(1):1267. doi: 10.1186/s12885-021-09006-w.
7
Inhibition of Fatty Acid Synthesis Aggravates Brain Injury, Reduces Blood-Brain Barrier Integrity and Impairs Neurological Recovery in a Murine Stroke Model.在小鼠中风模型中,抑制脂肪酸合成会加重脑损伤、降低血脑屏障完整性并损害神经功能恢复。
Front Cell Neurosci. 2021 Aug 16;15:733973. doi: 10.3389/fncel.2021.733973. eCollection 2021.
8
Proteomic Profiling of Ectosomes Derived from Paired Urothelial Bladder Cancer and Normal Cells Reveals the Presence of Biologically-Relevant Molecules.配对的膀胱癌和正常细胞来源的外泌体的蛋白质组学分析揭示了具有生物学相关性的分子的存在。
Int J Mol Sci. 2021 Jun 24;22(13):6816. doi: 10.3390/ijms22136816.
9
Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer.白藜芦醇、姜黄素、紫杉醇和微小RNA介导的PI3K/Akt/mTOR信号通路调控:治疗膀胱癌更上一层楼。
Cancer Cell Int. 2020 Nov 23;20(1):560. doi: 10.1186/s12935-020-01660-7.
10
Fatty Acid Synthase: An Emerging Target in Cancer.脂肪酸合酶:癌症治疗的新兴靶点。
Molecules. 2020 Aug 28;25(17):3935. doi: 10.3390/molecules25173935.